Ultra-low-dose same-target combinations control drug resistance across stages
Z.-G. Zhao, Shao-Qing Cai, R. Tan…·F. Xu
This study shows that combining multiple low-dose inhibitors targeting the same oncogenic driver can delay drug resistance in cancer models.